Largest pharmaceutical companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 pharmaceutical companies ranked by total assets, at ZAR 3.6T, ahead of Johnson & Johnson (ZAR 3.44T) and Sanofi (ZAR 2.43T). Figures as of 18 Nov 2026, 19:17 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerZAR 3.6T
- Median
- ZAR 60.9B
- Combined market value
- ZAR 87.69T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | ZAR 3.6T | ZAR 2.77T | ZAR 485.55 | 1.35% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | ZAR 3.44T | ZAR 11.4T | ZAR 4,736.01 | 1.71% down | 38% up | ||
| 3 | SanofiSNY · Health Care | ZAR 2.43T | ZAR 1.96T | ZAR 816.71 | 0.61% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | ZAR 2.37T | ZAR 5.86T | ZAR 2,377.08 | 4.10% down | 51% up | ||
| 5 | AbbVieABBV · Health Care | ZAR 2.32T | ZAR 8.76T | ZAR 4,955.32 | 2.12% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | ZAR 1.97T | ZAR 4.8T | ZAR 3,094.04 | 1.81% down | 2% up | ||
| 7 | Eli LillyLLY · Health Care | ZAR 1.94T | ZAR 21.39T | ZAR 24,012.60 | 1.88% down | 35% up | ||
| 8 | NovartisNVS · Health Care | ZAR 1.92T | ZAR 5.08T | ZAR 2,689.05 | 2.26% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | ZAR 1.68T | ZAR 1.18T | ZAR 368.92 | 1.39% down | 54% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | ZAR 1.56T | ZAR 2.12T | ZAR 1,035.49 | 2.37% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | ZAR 1.5T | ZAR 3.13T | ZAR 1,806.30 | 0.22% down | 17% down | ||
| 12 | GSKGSK · Health Care | ZAR 1.4T | ZAR 1.69T | ZAR 840.65 | 1.25% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | ZAR 1.39T | ZAR 3.01T | ZAR 683.50 | 2.86% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 704.5B | ZAR 849.2B | ZAR 727.76 | 1.23% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 701.2B | ZAR 1.69T | ZAR 16,359.75 | 1.20% down | 36% up | ||
| 16 | ViatrisVTRS · Health Care | ZAR 643B | ZAR 409B | ZAR 356.75 | 0.90% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 443.3B | ZAR 2.36T | ZAR 9,309.08 | 0.80% up | 27% up | ||
| 18 | GrifolsGRFS · Health Care | ZAR 378.1B | ZAR 99.2B | ZAR 145.83 | 2.26% down | 1% up | ||
| 19 | Royalty PharmaRPRX · Health Care | ZAR 339.2B | ZAR 689.4B | ZAR 1,198.96 | 0.98% up | 78% up | ||
| 20 | ZoetisZTS · Health Care | ZAR 267.4B | ZAR 600B | ZAR 1,476.78 | 2.32% up | 29% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | ZAR 230.9B | ZAR 232.8B | ZAR 465.67 | 4.20% up | 20% up | ||
| 22 | GenmabGMAB · Health Care | ZAR 222.6B | ZAR 547.5B | ZAR 887.94 | 1.15% down | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 201.6B | ZAR 273.6B | ZAR 4,262.48 | 2.43% up | 37% up | ||
| 24 | BeOne MedicinesONC · Health Care | ZAR 141.6B | ZAR 798.7B | ZAR 6,992.51 | 2.13% down | 17% up | ||
| 25 | United TherapeuticsUTHR · Health Care | ZAR 136.2B | ZAR 428B | ZAR 10,049.63 | 0.48% down | 23% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 131.3B | ZAR 203.6B | ZAR 1,050.97 | 3.90% up | 11% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 106.6B | ZAR 216.6B | ZAR 259.76 | 1.59% up | 5% up | ||
| 28 | Roivant SciencesROIV · Health Care | ZAR 98.7B | ZAR 481.3B | ZAR 664.31 | 0.74% down | 90% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 85.9B | ZAR 346.5B | ZAR 2,586.96 | 4.39% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 63.6B | ZAR 132.5B | ZAR 380.17 | 4.12% up | 83% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | ZAR 60.9B | ZAR 80.1B | ZAR 481.05 | 3.21% up | 64% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | ZAR 50.1B | ZAR 87B | ZAR 1,040.85 | 0.26% down | 20% down | ||
| 33 | AlkermesALKS · Health Care | ZAR 43B | ZAR 135.4B | ZAR 805.64 | 2.53% up | 58% up | ||
| 34 | InsmedINSM · Health Care | ZAR 39.2B | ZAR 456.4B | ZAR 2,080.50 | 1.25% down | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | ZAR 30B | ZAR 54.3B | ZAR 279.90 | 0.50% up | 42% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | ZAR 27B | ZAR 103.8B | ZAR 5,191.05 | 2.20% up | 43% up | ||
| 37 | Ascendis PharmaASND · Health Care | ZAR 25B | ZAR 306.5B | ZAR 4,673.17 | 0.33% down | 28% up | ||
| 38 | CytokineticsCYTK · Health Care | ZAR 24.6B | ZAR 123B | ZAR 883.27 | 1.08% down | 20% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 23.9B | ZAR 105.4B | ZAR 745.74 | 0.34% up | 10% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 21.8B | ZAR 160.9B | ZAR 6,926.25 | 5.06% down | 24% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | ZAR 18.4B | ZAR 172.2B | ZAR 1,139.57 | 5.11% up | 107% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | ZAR 16.2B | ZAR 147.7B | ZAR 5,282.93 | 0.17% up | 61% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | ZAR 16.2B | ZAR 84.1B | ZAR 483.47 | 0.41% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | ZAR 16.2B | ZAR 262.3B | ZAR 1,346.26 | 1.39% up | 17% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 14.6B | ZAR 103.2B | ZAR 1,580.86 | 0.55% down | 31% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | ZAR 14.5B | ZAR 128.2B | ZAR 1,171.47 | 3.30% down | 8% down | ||
| 47 | Belite BioBLTE · Health Care | ZAR 13.5B | ZAR 110B | ZAR 2,709.19 | 0.64% down | 31% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | ZAR 13.4B | ZAR 162.3B | ZAR 1,708.62 | 5.35% up | 286% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 13.2B | ZAR 129.3B | ZAR 1,645.17 | 0.05% up | 126% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | ZAR 13B | ZAR 146.2B | ZAR 182.83 | 0.89% down | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | ZAR 11.9B | ZAR 121.9B | ZAR 2,316.66 | 1.43% down | 7% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | ZAR 11.6B | ZAR 141.5B | ZAR 2,167.98 | 0.59% up | 46% up | ||
| 53 | ABIVAXABVX · Health Care | ZAR 11.2B | ZAR 126.6B | ZAR 1,446.10 | 1.88% up | 27% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | ZAR 10.5B | ZAR 84.1B | ZAR 876.53 | 0.78% down | 44% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | ZAR 9.6B | ZAR 78.7B | ZAR 719.03 | 1.07% down | 88% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | ZAR 9.2B | ZAR 84.1B | ZAR 1,493.03 | 0.71% down | 113% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | ZAR 8.4B | ZAR 111.8B | ZAR 1,648.54 | 1.00% down | 241% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 8.3B | ZAR 144.7B | ZAR 2,087.59 | 3.55% up | 13% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | ZAR 7.6B | ZAR 67.7B | ZAR 494.45 | 2.65% down | 169% up | ||
| 60 | ErascaERAS · Health Care | ZAR 6.8B | ZAR 81.3B | ZAR 231.67 | 3.53% down | 403% up | ||
| 61 | VeradermicsMANE · Health Care | ZAR 2.6B | ZAR 90.6B | ZAR 2,147.23 | 1.15% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2885 ZAR).
Questions and answers
Which pharmaceutical companies rank first by total assets?
Pfizer (ZAR 3.6T), Johnson & Johnson (ZAR 3.44T) and Sanofi (ZAR 2.43T) are the top three of the 61 pharmaceutical companies ranked by total assets as of 18 Nov 2026, 19:17 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by total assets.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by total assets have a combined market value of ZAR 87.69T as of 18 Nov 2026, 19:17 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.